Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Ana Oaknin, Anne Floquet, Christophe Le Tourneau, Isabelle Laure Ray-Coquard, Florence Joly, Manuel Hidalgo, Alexandra Leary, Oliver Krieter, Angelika Lahr, Simona Rossomanno, Katharina Lechner, Tapan Nayak, Christophe Boetsch, Grozdana Rasuo, Anthony Mor | ||||||||||||
Title | Single agent vanucizumab (RO5520985) for platinum (Pt)-resistant recurrent ovarian cancer (OC): Results from a single arm extension phase of the phase I FIH study. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/149637-156 | ||||||||||||
Abstract Text | J Clin Oncol 33, 2015 (suppl; abstr 5549) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|